Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 19;26(6):2756.
doi: 10.3390/ijms26062756.

The Role of Platelet Dysfunctions in the Pathogenesis of the Hemostatic-Coagulant System Imbalances

Affiliations
Review

The Role of Platelet Dysfunctions in the Pathogenesis of the Hemostatic-Coagulant System Imbalances

Oana-Viola Badulescu et al. Int J Mol Sci. .

Abstract

Platelet dysfunction plays a critical role in the pathogenesis of various disorders affecting the hemostatic-coagulant system. This review aims to explore the mechanisms by which platelet dysfunctions contribute to the disruption of hemostasis, leading to an increased risk of both thrombosis and bleeding. Platelets, traditionally known for their role in clot formation, can exhibit altered functionality under pathological conditions such as cardiovascular diseases, metabolic disorders, and autoimmune diseases, impacting their interaction with coagulation factors and vascular endothelium. The review discusses the molecular and cellular mechanisms underlying platelet dysfunction, including aberrations in platelet activation, aggregation, and secretion. It also highlights the interplay between platelets and other components of the coagulation cascade, such as fibrinogen and clotting factors, in maintaining vascular integrity. Moreover, the review examines clinical implications, including how platelet dysfunction can be a contributing factor in conditions like deep vein thrombosis, stroke, and disseminated intravascular coagulation (DIC). Finally, current therapeutic approaches targeting platelet dysfunctions, including antiplatelet agents and emerging therapies, are reviewed to provide insights into potential strategies for managing fluid-coagulation system imbalances. This review underscores the importance of a comprehensive understanding of platelet dysfunction to improve diagnosis and treatment of hemostatic disorders.

Keywords: hemostasis; platelet dysfunction; the hemostatic-coagulant system; thrombosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of primary hemostasis: platelet adhesion at the site of vascular injury, mediated by von Willebrand factor, which binds to GP Ib-IX receptors, followed by platelet aggregation through fibrinogen bridges bound to GP IIb-IIIa receptors, ultimately leading to the formation of the platelet thrombus.

Similar articles

References

    1. Vinholt P.J. The role of platelets in bleeding in patients with thrombocytopenia and hematological disease. Clin. Chem. Lab. Med. 2019;57:1808–1817. doi: 10.1515/cclm-2019-0380. - DOI - PubMed
    1. Yeung J., Li W., Holinstat M. Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases. Pharmacol. Rev. 2018;70:526–548. doi: 10.1124/pr.117.014530. - DOI - PMC - PubMed
    1. Coller B.S., Shattil S.J. The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: A technology-driven saga of a receptor with twists, turns, and even a bend. Blood. 2008;112:3011–3025. doi: 10.1182/blood-2008-06-077891. - DOI - PMC - PubMed
    1. Zou Z., Chen H., Schmaier A.A., Hynes R.O., Kahn M.L. Structure-function analysis reveals discrete beta3 integrin inside-out and outside-in signaling pathways in platelets. Blood. 2007;109:3284–3290. doi: 10.1182/blood-2006-10-051664. - DOI - PubMed
    1. Sible A.M., Nawarskas J.J. Cangrelor: A new route for P2Y12 inhibition. Cardiol. Rev. 2017;25:133–139. doi: 10.1097/CRD.0000000000000142. - DOI - PubMed

LinkOut - more resources